keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
This Mitogen-activated protein kinase (MAP kinase) fragment has a peptide sequence of Lys-Tyr-Ile-His-Ser-Ala-Asn-Val-Leu. The MAP kinases are serine/threonine-specific protein kinases belonging to the CMGC (CDK/MAPK/GSK3/CLK) kinase group.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | お問い合わせ | ¥ 11,500 |
5 mg | お問い合わせ | ¥ 33,000 |
10 mg | お問い合わせ | ¥ 54,000 |
25 mg | お問い合わせ | ¥ 75,500 |
説明 | This Mitogen-activated protein kinase (MAP kinase) fragment has a peptide sequence of Lys-Tyr-Ile-His-Ser-Ala-Asn-Val-Leu. The MAP kinases are serine/threonine-specific protein kinases belonging to the CMGC (CDK/MAPK/GSK3/CLK) kinase group. |
In vitro | MAPK pathways are a collection of protein signaling cascades stimulated by a wide variety of extracellular signals, including growth factors, cytokines, and environmental stresses. Upon activation, MAPK pathways regulate many fundamental cellular functions, includ-ing differentiation, proliferation, and apoptosis, through the activation of specific transcription factors and other regulatory proteins. MAPKs are involved in directing cellular responses to a diverse array of stimuli, such as mitogens, osmotic stress, heat shock, and proinflammatory cytokines. MAPK proteins have been repeatedly implicated in the pathogenesis of cancer and autoimmune diseases, leading to their selection as targets for drug development. |
分子量 | 1044.2 |
分子式 | C48H77N13O13 |
CAS No. | TP2269 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: ≥104.4mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MAP kinase fragment [Multiple species] TP2269 Others Inhibitor inhibitor inhibit